Literature DB >> 26805009

Design and functionality of a smart fentanyl iontophoretic transdermal system for the treatment of moderate-to-severe postoperative pain.

Nitin Joshi1, John Lemke1, Hassan Danesi1.   

Abstract

Fentanyl iontophoretic transdermal system (ITS) is a patient-controlled analgesia system used for the management of acute postoperative pain. The first-generation fentanyl ITS was an integrated one-piece system; however, corrosion that could limit reliability was detected in a small number of systems. A second-generation fentanyl ITS was designed to separate the hydrogels in the Drug Unit from the electronic circuit of the Controller during manufacture and storage, removing the primary cause of corrosion and thereby improving reliability. No evidence of corrosion has been observed in over 10,000 systems tested in real-time aging studies for the second generation fentanyl ITS. The second generation fentanyl ITS design features combine to ensure safe operation of the system with high reliability.

Entities:  

Keywords:  IONSYS; design; fentanyl; iontophoretic transdermal system; patient-controlled analgesia

Mesh:

Substances:

Year:  2016        PMID: 26805009     DOI: 10.2217/pmt.15.70

Source DB:  PubMed          Journal:  Pain Manag        ISSN: 1758-1869


  6 in total

Review 1.  Fentanyl Formulations in the Management of Pain: An Update.

Authors:  Stephan A Schug; Sonya Ting
Journal:  Drugs       Date:  2017-05       Impact factor: 9.546

Review 2.  Fentanyl Iontophoretic Transdermal System: A Review in Acute Postoperative Pain.

Authors:  Lesley J Scott
Journal:  Clin Drug Investig       Date:  2016-04       Impact factor: 2.859

3.  Comparison of fentanyl iontophoretic transdermal system and routine care with morphine intravenous patient-controlled analgesia in the management of early postoperative mobilisation: results from a randomised study.

Authors:  Richard M Langford; Kuang-Yi Chang; Li Ding; Jeffrey Abraham
Journal:  Br J Pain       Date:  2016-09-15

4.  Fentanyl Iontophoretic Transdermal System (IONSYS(®)) can be Safely used in the Hospital Environment with X-Rays, Computerized Tomography and Radiofrequency Identification Devices.

Authors:  John Lemke; Edmond Sardariani; Joseph Bradley Phipps; Niki Patel; Loretta M Itri; James Caravelli; Eugene R Viscusi
Journal:  Adv Ther       Date:  2016-07-16       Impact factor: 3.845

Review 5.  Patient considerations in the use of transdermal iontophoretic fentanyl for acute postoperative pain.

Authors:  Craig T Hartrick; Cecile R Pestano; Li Ding; Hassan Danesi; James B Jones
Journal:  J Pain Res       Date:  2016-04-19       Impact factor: 3.133

Review 6.  Quo Vadis PCA? A Review on Current Concepts, Economic Considerations, Patient-Related Aspects, and Future Development with respect to Patient-Controlled Analgesia.

Authors:  S Nardi-Hiebl; L H J Eberhart; M Gehling; T Koch; T Schlesinger; P Kranke
Journal:  Anesthesiol Res Pract       Date:  2020-02-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.